---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-014676"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2023-01-25T23:59:59+00:00"
generated_at: "2026-06-20T09:11:13.528170+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q4 GAAP EPS $3.93, adj. $5.23; revenue up 10.1% to $39.7B; FY revenue $155.7B; dividend raised 16%

## Summary
- GAAP EPS Q4 $3.93, FY $24.81; adjusted EPS Q4 $5.23, FY $29.07.
- Full-year operating revenue $155.7B (+13.7% YoY); operating gain $8.5B (+12.9%).
- Medical membership 47.5M (+2.2M YoY); growth in Medicaid, commercial fee-based.
- Quarterly dividend raised 16% to $1.48; new annualized rate $5.92 per share.
- Board authorized $5.0B increase to share repurchase program; 2023 guidance: GAAP EPS >$29.80, adjusted >$32.60.

## SEC filing metadata
- accession: 0001193125-23-014676
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2023-01-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/d418386d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-014676
- JSON: https://secwatch.observer/filing/0001193125-23-014676.json
- Plain text: https://secwatch.observer/filing/0001193125-23-014676.txt

## Key facts
- Earnings Releases
  Elevance Health, Inc. reported year ending December 31, 2023 results: EPS greater than $29.80 per share. Guidance initiated.
  - Period: year ending December 31, 2023
  - EPS: greater than $29.80 per share
  - Guidance: initiated
  - Result: guidance update
  source text: The Company expects GAAP net income to be greater than $29.80 per share in 2023, and adjusted net income to be greater than $32.60 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm
- Earnings Releases
  Elevance Health, Inc. reported year ended December 31, 2022 results: revenue $156 billion, EPS $24.81 per share.
  - Period: year ended December 31, 2022
  - Revenue: $156 billion
  - EPS: $24.81 per share
  - Result: reported results
  source text: • Fourth quarter and full year GAAP net income was $3.93 and $24.81 per share • Fourth quarter and full year adjusted net income was $5.23* and $29.07* per share • Full year operating revenue grew 13.7% year-over-year to $156 billion • Full year operating gain grew 12.9% year-over-year to $8.5 billion • Medical enrollment increased 2.2 million members year-over-year to 47.5 million members • Quarterly dividend increased by 16% to $1.48 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm
- Earnings Releases
  Elevance Health, Inc. reported quarter ended December 31, 2022 results: EPS $3.93 per share.
  - Period: quarter ended December 31, 2022
  - EPS: $3.93 per share
  - Result: reported results
  source text: GAAP net income was $3.93 per share in the fourth quarter, including net negative adjustment items of $1.30 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.